Buprenorphine, particularly in the long-acting injectable form known as Buvidal, has become a cornerstone in modern opioid dependence treatment. As a partial opioid agonist, it helps manage withdrawal symptoms and cravings while carrying a lower risk of misuse compared to full agonists like methadone. This 2000-word guide explores its mechanism, clinical effectiveness, safety profile, regulatory […]
The landscape of modern addiction medicine has evolved significantly with the introduction of long-acting injectable therapies. For decades, individuals undergoing opioid agonist therapy relied almost exclusively on daily sublingual medications or liquid solutions. Managing daily administration presented ongoing challenges, including public stigma, strict pharmacy visitation schedules, and the risk of accidental diversion or missed doses. […]
The scientific investigation of ibogaine as a potential intervention for addiction has evolved from anecdotal reports and observational studies to more rigorous clinical research over the past three decades. While the compound remains in a complex regulatory position across much of the world, preventing large-scale randomized controlled trials in many jurisdictions, a growing body of […]